Executive Director, Global Publications, Scientific Communications, and Medical Information

Waltham, MA (On-site)

$261K/yr – $326K/yrSenior Level12+ years expFull time

Posted 5 days ago

Job Description

Responsibilities

  • Strategic Scientific Communications & Narrative Generation
  • Architect and operationalize global strategic scientific communication platforms (SSCP) and core scientific statements across all development and lifecycle stages.
  • Partner cross-functionally with Clinical Development, Translational Medicine, Regulatory Affairs, and Commercial Strategy to ensure integrated, scientifically rigorous narratives aligned with clinical value propositions.
  • Lead the creation and lifecycle maintenance of internal medical education assets, scientific slide decks, standard training curriculums, and field medical resources (e.g., MSL slide decks, scientific exchange tools).
  • Champion digital and omnichannel scientific communication innovations, expanding the reach and engagement of peer-reviewed data through enhanced publication content (visual abstracts, video commentaries, plain-language summaries).
  • Global Publication Strategy & Delivery
  • Serve as global lead for scientific communications across the product pipeline and portfolio, driving strategic vision while actively executing publication planning, publication development, literature surveillance, and development of internal training materials and external scientific tools.
  • Direct the strategic design, governance, and tactical execution of global integrated publication plans (IPPs) across journals, congresses, and symposia.
  • Drive timely, high-impact publication of Phase 1-3 clinical trial results, real-world evidence (RWE), health economics and outcomes research (HEOR), and preclinical/translational data.
  • Lead cross-functional Publication Steering Committees (PSCs), overseeing external author selection, engagement, review rounds, and publication development in strict adherence to ICMJE guidelines, GPP (Good Publication Practice), and company compliance standards.

Requirements

  • Doctorate degree required: PharmD, PhD, or MD in life sciences, pharmacology, or a related biomedical discipline.
  • 12+ years of progressive experience in the biopharmaceutical industry within Medical Affairs, including dedicated focus in Scientific Communications, Global Publications, and Medical Information.
  • 5+ years of direct people-management and matrix-leadership experience, with a track record of hiring, mentoring, and retaining talent.
  • Deep therapeutic area expertise in rheumatology, immunology, neurology, or rare disease is required.
  • Thorough command of industry regulations and guidelines governing scientific communications: ICMJE, GPP3/GPP2022, PhRMA Code, FDA guidance on scientific exchange, OIG, and Sunshine Act/transparency regulations.
  • Demonstrated experience launching first-in-class or best-in-class assets, leading late-stage pivotal publication disclosures (Phase 3 primary endpoints), and standing up launch-ready Medical Information operations.
  • Experience overseeing medical communications vendors, contract research/medical writing agencies, and contact centers.
  • Skills & Competencies
  • Exceptional written and verbal communication skills, with the ability to distill complex mechanistic science into clear, evidence-based messages.
  • Executive presence and cross-functional leadership, adept at navigating clinical development, commercial, regulatory, and external Key Opinion Leader (KOL) interfaces.

Benefits

  • annual performance bonus, equity, full range of benefits and other incentive compensation plans.
Zenas BioPharma logo

Zenas BioPharma

5.0 Glassdoor

Zenas BioPharma (Nasdaq: ZBIO) is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. We believe that obexelimab’s mechanism of action and chronic dosing regimen may broadly and effectively address the pathogenic role of B cell lineage in chronic autoimmune disease.

Founded in 2020
Waltham, Massachusetts, USA
148 employees (5 in marketing)
100% recommend to a friend

Salaries

Posted range

$261K/yr – $326K/yr

Taken straight from the job posting.

Communications median pay in the United States

$93K/yr

Most pay falls between $70K and $138K. Based on 5,779 salaries.

See all Zenas BioPharma salaries

Marketing Team

Marketing Team Size
5 (3% of company)
Median Tenure
1.4 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$513M
Last Raise
$120M
Post IPO Equity, 5 months ago

Funding History

  • Oct 2025
    Post IPO Equity • $120M
  • Sep 2025
    Post IPO Debt • $75M
  • May 2024
    Series C • $200M

Traffic Signals

Monthly Visitors
6.7K
Traffic Source Mix
Search
33.9%
Direct
43.7%
Referral
5.4%
Social
15.6%
Paid
1.3%

Headcount Trend

Current headcount: ~149

Recent News